Showing results (341-350 of 771) with videos related to

Sort By:
Pageof 78
Atherosclerosis|April 16, 2011
T cell activation predicts carotid artery stiffness among HIV-infected womenRobert C Kaplan, Elizabeth Sinclair, Alan L Landay, et al.
AIDS (London, England)|October 26, 2013
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollersHiroyu Hatano, Ma Somsouk, Elizabeth Sinclair, et al.
Journal of Immunological Methods|December 9, 2003
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cellsAnnika C Karlsson, Jeffrey N Martin, Sophie R Younger, et al.
Retrovirology|August 25, 2016
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapyVanessa Sue Wacleche, Jean-Philippe Goulet, Annie Gosselin, et al.
AIDS (London, England)|July 11, 2009
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expressionJennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, et al.
Journal of Virology|August 20, 2010
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responsesApril L Ferre, Peter W Hunt, Delandy H McConnell, et al.
The Journal of Infectious Diseases|October 16, 2021
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral TherapyJared Stern, Ajantha Solomon, Ashanti Dantanarayana, et al.
AIDS (London, England)|August 14, 2013
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllersAlice K Asher, Glenn-Milo Santos, Jennifer Evans, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Immunophenotype and Proviral Landscape of HIV-infected CD4 T Cells During Antiretroviral TherapyCyrille L Delley, Sakshi Shah, Kevin M Joslin, et al.
Pageof 78